Daniel Delgado‐Bellido
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 5
-
- PARP inhibition in cancer therapy 4
-
- Angiogenesis and VEGF in Cancer 6
- Cell death mechanisms and regulation 2
- Wnt/β-catenin signaling in development and cancer 2
- Cancer therapeutics and mechanisms 1
-
- Cell Adhesion Molecules Research 3
-
- Autophagy in Disease and Therapy 4
- Co-authors
- F. Javier OliverMónica Fernández‐CortésSantiago SerranoÁngel García-DíazEnrique de ÁlavaAna Teresa AmaralArkaitz CarracedoMaría Isabel Rodríguez
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Daniel Delgado‐Bellido
17 papers receiving 483 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 182
- Oncology 175
- Molecular Biology 339
- Immunology and Allergy 29
- Immunology 56
Countries citing papers authored by Daniel Delgado‐Bellido
This map shows the geographic impact of Daniel Delgado‐Bellido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Delgado‐Bellido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Delgado‐Bellido more than expected).
Fields of papers citing papers by Daniel Delgado‐Bellido
This network shows the impact of papers produced by Daniel Delgado‐Bellido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Delgado‐Bellido. The network helps show where Daniel Delgado‐Bellido may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Delgado‐Bellido, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 30 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 41 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 42 | |
| 15 | 2019 | 94 | |
| 16 | 2019 | 11 | |
| 17 | 2018 | 43 | |
| 18 | 2017 | 170 |
About Daniel Delgado‐Bellido
Daniel Delgado‐Bellido is a scholar working on Immunology and Allergy, Cancer Research and Geriatrics and Gerontology, having authored 18 papers that have together received 488 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Autophagy in Disease and Therapy (4 papers), PARP inhibition in cancer therapy (4 papers), Cell Adhesion Molecules Research (3 papers), Cell death mechanisms and regulation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Cancer Research (182 citations), Oncology (175 citations) and Molecular Biology (339 citations). Daniel Delgado‐Bellido has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include F. Javier Oliver, Mónica Fernández‐Cortés, Santiago Serrano, Ángel García-Díaz, Enrique de Álava, Ana Teresa Amaral, Arkaitz Carracedo, María Isabel Rodríguez, Francisco O′Valle and José Expósito. Their work appears in journals such as Cancers, Frontiers in Oncology, Cell Death and Disease, International Journal of Molecular Sciences and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.